4 June 2021 · The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.
2 October 2018 · This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T Therapy.
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
16 November 2021 · A single Patient Group Direction (PGD) can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.
31 October 2023 · Users should be aware of the constraints and assumptions in creating our annual Prescribing Outlook publications, as well as their responsibilities for use.